ArticleBMC oral health2025
PMAIP1 mediates endoplasmic reticulum stress in human dental pulp stem cells during pulpitis pathogenesis.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundPulpitis, characterized by dental pulp inflammation, significantly impacts oral health, yet its molecular mechanisms remain poorly understood. This study investigated the role of endoplasmic reticulum (ER) stress in pulpitis pathogenesis and explored its therapeutic potential.
methodsWe examined ER stress markers in human pulpitis specimens and lipopolysaccharide (LPS)-treated human dental pulp stem cells (hDPSCs). Transcriptomic analysis of public datasets (GSE98359) was performed to identify ER stress-related differentially expressed genes (DEGs). The therapeutic efficacy of 4-phenylbutyric acid (4-PBA), an ER stress inhibitor, was evaluated in both in vitro and in vivo pulpitis models.
resultsSignificantly elevated expression of BiP and CHOP was observed in pulpitis specimens and LPS-treated hDPSCs. Bioinformatic analysis identified 19 ER stress-related DEGs in pulpitis, with PMAIP1 emerging as central regulators. Pathway analysis revealed significant enrichment in ER stress response, inflammatory signaling, and apoptotic pathways. 4-PBA treatment effectively attenuated both LPS-induced ER stress and inflammatory responses in hDPSCs and experimental pulpitis.
conclusionsOur findings establish ER stress as a critical mediator in pulpitis pathogenesis and PMAIP1 is identified as a key regulatory hub. The therapeutic efficacy of 4-PBA suggests that targeting ER stress represents a promising strategy for pulpitis treatment. CLINICAL SIGNIFICANCE: The demonstration of 4-PBA therapeutic efficacy provides a strong foundation for developing novel treatments targeting ER stress in pulpitis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.